Crinetics Pharmaceuticals, Inc. (DELISTED) (CRNX:DL)
84.95
0.00 (0.00%)
USD |
NASDAQ |
Sep 10, 16:00
Crinetics Pharmaceuticals Profit Margin (Quarterly) : -481.1% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -481.1% |
| March 31, 2026 | -1.19K% |
| December 31, 2025 | -1.99K% |
| September 30, 2025 | -90.97K% |
| June 30, 2025 | -11.22K% |
| March 31, 2025 | -26.81K% |
| December 31, 2024 | |
| September 30, 2024 | |
| June 30, 2024 | |
| March 31, 2024 |
| Date | Value |
|---|---|
| December 31, 2023 | |
| September 30, 2023 | |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | -6.35K% |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | -2.86K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | 32.89% |
| Johnson & Johnson | 21.86% |
| Eli Lilly & Co. | 30.88% |
| Bristol Myers Squibb Co. | 25.54% |
| Corcept Therapeutics, Inc. | 16.45% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -43.94% |
| Return on Assets | -39.53% |
| Return on Invested Capital | -42.14% |
| Gross Profit Margin (Quarterly) | 95.12% |
| Operating Margin (Quarterly) | -527.3% |
| Return on Net Operating Assets | -838.4% |